MPTRVT

Labsystems Diagnostics’ Bordetella pertussis EIA tests

• Pertussis toxin (PT) is a specific antigen for the detection of Bordetella pertussis, the use of PT is also recommended by the European guidelines (European Center for the Disease Prevention and Control)
• Whole cell antigen tests also available
• The kits come with ready-to-use, well sufficient reagents and breakable, coded strips.
• IgG Remover (RF absorbent) is included in the IgM kits, no separate reagents or steps are needed.
• The kits are suitable for different automatic systems and manual testing.
• Multi-testing with other LDx tests is easy due to interchangeable reagents, like buffers and substrate, and similar test procedures.
• Internal and external quality monitoring maintain constant quality

• Chain-of-custody verification eliminates possibility for sample mix-up
• Instrument matches the barcode on vial with the label on slide to ensure sample is placed on correct slide
• Walk away automation
• Able to process between 1 and 20 samples per batch allowing flexible walk away automation
• Supports processing of multiple slides per vial
• Automated vial handling enables operator to simply load and leave
• Batch processing may be interrupted in order to run an urgent sample

Cystic Fibrosis (CF) is an autosomal recessive disorder affecting the lungs, pancreas, intestine and liver. CF is the most common in Caucasians with an incidence rate 1:2500 newborns. CF is caused by mutation in the gene for the protein cystic fibrosis transmembrane conductance regulator (CTFR) [1,2]. Large-scale neonatal screening for CF is performed by indentification of increased levels of immunoreactive trypsinogen (IRT) in blood.

Labsystems Diagnostics’ Neonatal Toxoplasma gondii IgM FEIA is a fluorometric enzyme immunoassay intended for the determination of IgM-class antibodies to Toxoplasma gondii in blood samples dried on filter paper. The test is intended as a primary method for screening newborns for congenital toxoplasmosis (CT).